Literature DB >> 10940709

Alterations in expression of cadherin-6 and E-cadherin during kidney development and in renal cell carcinoma.

T Shimazui1, J Oosterwijk-Wakka, H Akaza, P P Bringuier, E Ruijter, F M Debruyne, J A Schalken, E Oosterwijk.   

Abstract

OBJECTIVES: Cell-cell adhesion mediated by cadherins is tight and stable and preserves tissue integrity. However, during tissue remodeling, e.g., development, adhesion may be modified for morphogenic movement. Similarly, during carcinogenesis, cell-cell adhesion might alter leading to a more aggressive phenotype. Here we describe cadherin expression patterns in developing, adult, and neoplastic kidney.
METHODS: Fetal kidneys were obtained from voluntary terminations of pregnancy and 43 renal cell carcinomas (RCC) and normal kidneys were obtained at nephrectomy. Frozen sections of these specimens were stained immunohistochemically using antibodies against E-cadherin (ECD), cadherin-6 (CAD6) and alpha-catenin (alpha-cat).
RESULTS: CAD6 was expressed in lower and middle limbs of the S-shaped bodies, structures that will develop into renal proximal tubules, which also express CAD6. Similarly, ECD was expressed in the upper limb of S-shaped bodies, structures which will develop into distal and collecting tubules which also express ECD. Twenty-four out of 43 RCC (55.8%) displayed a CAD6 (+)/ECD (-)/alpha-cat (+) phenotype. The other RCC had a CAD6 (+)/ECD (+)/alpha-cat (+) phenotype (10/43, 23.2%), CAD6 (-)/ECD (+)/alpha-cat (+) phenotype (3/43, 7.0%) or CAD6 (-)/ECD (-)/alpha-cat (+) phenotype (6/43, 14.0%), respectively. On the other hand, normal, heterogeneous, or absent expression of CAD6 was seen in 19, 15, and 9 tumors, whereas in 11, 2, and 30 tumors, respectively, ECD expression was seen. Survival curves showed that abnormal CAD6 expression correlated with a poor prognosis rather than abnormal ECD expression.
CONCLUSIONS: The combination of cadherin expression appeared to be fixed relatively early during kidney organogenesis. Since almost all RCC originate from proximal tubular epithelial cells (CAD6 (+)/ECD (-)/alpha-cat (+)), only 55. 8% of RCC retained the original cadherin phenotype. Alterations in expression of these molecules may be a reflection of the degree of dedifferentiation from the primary organ. In addition, scoring of expression patterns including heterogeneous expression could be a useful tool to estimate the malignancy potential of the tumor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10940709     DOI: 10.1159/000020302

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  8 in total

1.  Molecular phenotypes of acute kidney injury in kidney transplants.

Authors:  Konrad S Famulski; Declan G de Freitas; Chatchai Kreepala; Jessica Chang; Joana Sellares; Banu Sis; Gunilla Einecke; Michael Mengel; Jeff Reeve; Philip F Halloran
Journal:  J Am Soc Nephrol       Date:  2012-02-16       Impact factor: 10.121

2.  Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation.

Authors:  Qianghua Hu; Fei Gao; Weihua Tian; E Cristy Ruteshouser; Yaqing Wang; Alexander Lazar; John Stewart; Louise C Strong; Richard R Behringer; Vicki Huff
Journal:  J Clin Invest       Date:  2010-12-01       Impact factor: 14.808

Review 3.  Cell adhesion molecules in chemically-induced renal injury.

Authors:  Walter C Prozialeck; Joshua R Edwards
Journal:  Pharmacol Ther       Date:  2007-01-23       Impact factor: 12.310

4.  Differential expression of E-cadherin and beta catenin in primary and metastatic Wilms's tumours.

Authors:  J Alami; B R Williams; H Yeger
Journal:  Mol Pathol       Date:  2003-08

5.  Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization.

Authors:  M J Stassar; G Devitt; M Brosius; L Rinnab; J Prang; T Schradin; J Simon; S Petersen; A Kopp-Schneider; M Zöller
Journal:  Br J Cancer       Date:  2001-11-02       Impact factor: 7.640

Review 6.  Circulating Tumor Cells for the Management of Renal Cell Carcinoma.

Authors:  Lucile Broncy; Patrizia Paterlini-Bréchot
Journal:  Diagnostics (Basel)       Date:  2018-09-03

Review 7.  Transglutaminase 2: The Maestro of the Oncogenic Mediators in Renal Cell Carcinoma.

Authors:  Ayca Ece Nezir; Burge Ulukan; Dilek Telci
Journal:  Med Sci (Basel)       Date:  2019-02-06

8.  Differential expression of E-cadherin, N-cadherin and beta-catenin in proximal and distal segments of the rat nephron.

Authors:  Walter C Prozialeck; Peter C Lamar; Denah M Appelt
Journal:  BMC Physiol       Date:  2004-05-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.